Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06003231
Title A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Seagen Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | ESP | CAN | AUS


No variant requirements are available.